Claritev

Claritev CROIC

The Cash Return on Invested Capital (CROIC) of Claritev (CTEV) as of Oct 15, 2026 is -0.28 %. In the previous year, Cash Return on Invested Capital (CROIC) was -0.23 % — a change of 21.76% (lower).

CROIC

-0.28 %

YoY

21.76%

Last updated:

Cash Return on Invested Capital (CROIC) of Claritev is 2025 -0.28 % . Cash Return on Invested Capital (CROIC) of Claritev was 2024 -0.23 % . It decreases by 21.76% lower compared to the previous year.

The Claritev CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
2.95 USD
Jan 1, 2020
4.30 USD
Jan 1, 2021
4.42 USD
Jan 1, 2022
4.32 USD
Jan 1, 2023
1.01 USD
Jan 1, 2024
-0.23 USD
Jan 1, 2025
-0.28 USD
The Claritev CROIC history
YEARCROICYoY
-0.28 %+21.76%
-0.23 %-122.69%
1.01 %-76.72%
4.32 %-2.38%
4.42 %+2.96%
4.30 %+45.54%
2.95 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp, listed under the ticker CTEV with ISIN US62548M2098, is a health care company headquartered in New York City, United States. The company has 3,000 employees and completed its initial public offering on February 10, 2020. Claritev Corp operates within the health care sector, focusing on providing healthcare cost management solutions. Its services include analytics-based approaches to identify over-charges in medical claims, negotiating fair reimbursement for out-of-network costs, and developing preferred provider networks through contracted discounts with healthcare providers. The company also offers payment and revenue integrity services designed to detect and correct improper or unnecessary charges before or after claims processing, as well as solutions to address underpaid premium dollars. Claritev Corp utilizes a software-as-a-service platform that processes and analyzes data using descriptive, predictive, and prescriptive analytics to support its services. The company's website is https://www.multiplan.us/. Claritev Corp is engaged in the delivery of data-driven solutions aimed at optimizing healthcare spending and improving financial outcomes for its clients in the health care industry. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Cash Return on Invested Capital (CROIC) of Claritev is -0.28 % in 2025.

Cash Return on Invested Capital (CROIC) of Claritev changed from -0.23 % to -0.28 %, representing a 21.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Claritev since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Claritev with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Claritev

All Key Metrics — Claritev